Novo Nordisk will introduce an oral version of Wegovy to the country by 2027. The drug maker says the pill will launch after gaining regulatory approval. The shot form of Wegovy already is sold in Australia. The UK began selling the oral formula in June 2026. This suggests Novo is expanding sales in key markets. Australian regulators must approve the pill first. The oral version will work alongside the injectable version already on sale.